Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 24, 2023 07:33 ET | Source: Text Request

Text Request Honored with Inc. Power Partner Award for 2nd Year

CHATTANOOGA, TENN., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Text Request, the industry-leading business messaging platform, has been recognized as an Inc. Power Partner for the second year in a row....
October 22, 2023 02:30 ET | Source: Revolution Medicines, Inc.

Revolution Medicines Presents Promising Clinical Activity and Safety Data from Phase 1/1b Trial of RMC-6236

REDWOOD CITY, Calif., Oct. 22, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today...
October 09, 2023 18:30 ET | Source: Custom Market Insights

[Latest] Global Precision Fermentation Market Size/Share Worth USD 25.54 Billion by 2032 at a 45% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

Austin, TX, USA, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Precision Fermentation Market Size, Trends and Insights By Ingredient (Whey...
September 19, 2023 07:00 ET | Source: Revolution Medicines, Inc.

Revolution Medicines Doses First Patient in Phase 1/1b Clinical Trial of RMC-9805, an Oral, Covalent, Mutant-Selective KRASG12D(ON) Inhibitor

KRASG12D(ON) Inhibitor with highly differentiated mechanism of action being evaluated in patients with cancers harboring the KRASG12D mutation, the most common driver of RAS-addicted human cancers ...
August 24, 2023 09:30 ET | Source: Barrack Rodos & Bacine

Barrack, Rodos & Bacine Investigates Napco Security Technologies, Inc. (NSSC)

PHILADELPHIA, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Barrack, Rodos & Bacine (BR&B) is investigating Napco Security Technologies, Inc. (“Napco”) (NASDAQ: NSSC) for potential violations of federal...
August 17, 2023 16:05 ET | Source: Revolution Medicines, Inc.

Revolution Medicines Announces Publication Describing Molecular Basis of Tri-Complex Inhibitors Targeting Oncogenic RAS(ON) Proteins

Science Report on KRASG12C(ON)-Selective Inhibitors Provides Preclinical Proof-of-Principle for Company's RAS Innovation Engine and Broad Pipeline REDWOOD CITY, Calif., Aug. 17, 2023 (GLOBE...
August 03, 2023 16:05 ET | Source: Revolution Medicines, Inc.

Revolution Medicines to Report Financial Results for Second Quarter 2023 After Market Close on August 8, 2023

REDWOOD CITY, Calif., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing novel targeted therapies for RAS-addicted cancers,...
July 20, 2023 11:30 ET | Source: Custom Market Insights

[Latest] Global Precision Medicine Market Size/Share Worth USD 189.64 Billion by 2030 at a 11.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

Austin, TX, USA, July 20, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Precision Medicine Market Size, Trends and Insights By Technology (Big data...
July 18, 2023 08:07 ET | Source: Precedence Research

Precision Fermentation Market Size Will Grow USD 6,385 Million by 2032

Ottawa, July 18, 2023 (GLOBE NEWSWIRE) -- The precision fermentation market size was valued at USD 1,930 million in 2022. Precision fermentation is a technology that uses microorganisms, such as...
April 27, 2023 12:23 ET | Source: The Rosen Law Firm PA

EQUITY ALERT: ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Edgio, Inc. f/k/a Limelight Networks, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – EGIO, LLNW

NEW YORK, April 27, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Edgio,...